[artículo] 
inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 31-39

Título :	Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial
Tipo de documento:	texto impreso
Autores:	Yves Dion, Autor ; Lawrence Annable, Autor ; Paul Sandor, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 31-39
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Discinesia inducida por fármacos, Examen neurológico, Risperidona, Síndrome de Tourette.
Resumen:	A double-blind, placebo-controlled trial was performed to determine the efficacy and tolerability of 8 weeks of treatment with risperidone in the management of 48 adolescent and adult patients with Tourette syndrome. Twenty-four patients were randomly assigned to treatment with risperidone in doses of 0.5 to 6.0 mg/day, and 24 were assigned to placebo.
Link:	./index.php?lvl=notice_display&id=31091

[artículo] Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial [texto impreso] / Yves Dion, Autor ; Lawrence Annable, Autor ; Paul Sandor, Autor . - 2023 . - pp. 31-39.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 31-39

Palabras clave:	Discinesia inducida por fármacos, Examen neurológico, Risperidona, Síndrome de Tourette.
Resumen:	A double-blind, placebo-controlled trial was performed to determine the efficacy and tolerability of 8 weeks of treatment with risperidone in the management of 48 adolescent and adult patients with Tourette syndrome. Twenty-four patients were randomly assigned to treatment with risperidone in doses of 0.5 to 6.0 mg/day, and 24 were assigned to placebo.
Link:	./index.php?lvl=notice_display&id=31091